Fiberoptic Bronchoscopy Indications
Fiberoptic bronchoscopy (FOB) is indicated for both diagnostic and therapeutic purposes across a wide range of respiratory conditions, with the primary diagnostic indications being suspected malignancy, persistent/recurrent pneumonia, persistent atelectasis, and evaluation of airway abnormalities including stridor. 1
Diagnostic Indications
Primary Diagnostic Uses
Suspected Malignancy
- Endobronchial tumors - FOB achieves a minimum diagnostic yield of 80% when combining biopsies, brushings, and washings for endoscopically visible malignancy 1
- At least 5 bronchial biopsy specimens should be obtained along with brushings and washings 1
- Most common indication in clinical practice, with diagnostic yield of 51.1% for lung cancer 2
Infectious Disease Evaluation
- Suspected tuberculosis - particularly important in high-prevalence settings, with diagnostic yield of 41.4% 2
- Opportunistic infections - especially in immunocompromised patients 3
- Allows direct microbiological sampling from affected airways
Persistent or Recurrent Pneumonia
- When pneumonia fails to resolve with appropriate antibiotic therapy
- To identify underlying structural abnormalities or obstructing lesions 4, 3
Persistent Atelectasis
- Evaluation of collapsed lung segments that don't re-expand
- Particularly useful for identifying mucus plugs or endobronchial obstruction 3, 5
Diffuse Lung Disease
- Transbronchial lung biopsy with 4-6 samples from one lung 1
- Note: diagnostic yield is relatively poor for interstitial lung diseases 4
Airway Evaluation
Stridor Assessment
- Direct visualization of upper and lower airways
- Identification of structural abnormalities causing airway narrowing 4, 5
Abnormal Chest Radiograph
- Investigation of unexplained radiographic findings 5
Hemoptysis
Chronic Cough
- When other diagnostic modalities are unrevealing 5
Therapeutic Indications
Intensive Care Unit Applications
ICUs should have the facility to perform urgent and timely FOB for both therapeutic and diagnostic purposes 1. Specific therapeutic indications include:
Airway Management
- Evaluation of endotracheal tube patency and position 6
- Assessment of airway damage from toxins or prolonged intubation 6
- Facilitation of difficult intubation 6
- Evaluation of failed extubation 5
Secretion Management
Tracheostomy Evaluation
Interventional Procedures
Laser Bronchoscopy (typically requires rigid bronchoscopy)
- Inoperable lung cancer with endobronchial obstruction (success rate ~90% for trachea/main bronchi) 8
- Benign cicatricial stenosis (success rate ~90%) 8
- Any obstruction within central airways compromising ventilation 8
Special Populations
Pediatric Considerations
FOB is safe and effective in children with similar indications, though caution is warranted in children with pulmonary arterial hypertension due to increased complication risk 4. The procedure can be performed using sedation and local anesthesia, avoiding general anesthesia in most cases 7, 3.
Mechanically Ventilated Patients
- Patients in ICU should be considered high-risk for complications 1
- Continuous multi-modal physiological monitoring must be maintained during and after the procedure 1
- The internal diameter of the endotracheal tube must accommodate the bronchoscope 1
- Care must be taken to ensure adequate ventilation and oxygenation 1
Contraindications
Absolute Contraindication:
- Isolated extrinsic compression of airways (for laser bronchoscopy) 8
Relative Contraindications (Risk-Benefit Assessment Required): The decision to proceed is a balance between diagnostic benefit and individual patient risk 1. Exercise particular caution with:
- Severe hypoxemia
- Unstable cardiovascular status
- Severe coagulopathy
- Pulmonary arterial hypertension 4
Safety Considerations
FOB is an extremely safe procedure with mortality rate of 0.01-0.04% and major complication rate of 0.08-0.12% 1. The overall complication rate should be <5% 8, with minor complications occurring in approximately 2-7% of cases 5, 2.
Common complications include:
- Hypoxemia
- Minor bleeding
- Bronchospasm
- Transient respiratory arrest (rare)
- Pneumothorax (particularly with transbronchial biopsy) 2
Key Safety Measures: